HUP0003207A3 - Proliposome powders for inhalation stabilised by tocopherol, pharmaceutical compositions containing the same and the use of them - Google Patents
Proliposome powders for inhalation stabilised by tocopherol, pharmaceutical compositions containing the same and the use of themInfo
- Publication number
- HUP0003207A3 HUP0003207A3 HU0003207A HUP0003207A HUP0003207A3 HU P0003207 A3 HUP0003207 A3 HU P0003207A3 HU 0003207 A HU0003207 A HU 0003207A HU P0003207 A HUP0003207 A HU P0003207A HU P0003207 A3 HUP0003207 A3 HU P0003207A3
- Authority
- HU
- Hungary
- Prior art keywords
- stabilised
- tocopherol
- inhalation
- pharmaceutical compositions
- same
- Prior art date
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000843 powder Substances 0.000 title 1
- 229960001295 tocopherol Drugs 0.000 title 1
- 229930003799 tocopherol Natural products 0.000 title 1
- 235000010384 tocopherol Nutrition 0.000 title 1
- 239000011732 tocopherol Substances 0.000 title 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88441997A | 1997-06-27 | 1997-06-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0003207A2 HUP0003207A2 (en) | 2001-02-28 |
| HUP0003207A3 true HUP0003207A3 (en) | 2001-03-28 |
Family
ID=25384589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0003207A HUP0003207A3 (en) | 1997-06-27 | 1998-06-08 | Proliposome powders for inhalation stabilised by tocopherol, pharmaceutical compositions containing the same and the use of them |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1001749A1 (en) |
| JP (1) | JP2002510311A (en) |
| KR (1) | KR20010014163A (en) |
| CN (1) | CN1260713A (en) |
| AU (1) | AU729100B2 (en) |
| BR (1) | BR9810280A (en) |
| CA (1) | CA2295028A1 (en) |
| EE (1) | EE9900601A (en) |
| HU (1) | HUP0003207A3 (en) |
| ID (1) | ID23192A (en) |
| IL (1) | IL133478A0 (en) |
| IS (1) | IS5304A (en) |
| NO (1) | NO996439L (en) |
| NZ (1) | NZ501672A (en) |
| PL (1) | PL337723A1 (en) |
| SK (1) | SK184899A3 (en) |
| TR (1) | TR199903271T2 (en) |
| WO (1) | WO1999000111A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030236236A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| EP1138311A1 (en) * | 2000-03-28 | 2001-10-04 | Primacare S.A. | Proliposomes |
| EP1138310A1 (en) * | 2000-03-28 | 2001-10-04 | Primacare S.A. | Proliposomes |
| EP1138313A1 (en) * | 2000-03-28 | 2001-10-04 | Primacare S.A. | Proliposomes |
| JP5846711B2 (en) * | 2005-06-09 | 2016-01-20 | メダ アーベー | Methods and compositions for the treatment of inflammatory diseases |
| US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
| US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| EP2993995B1 (en) * | 2013-05-06 | 2018-04-11 | DSM IP Assets B.V. | Powderous vitamin e formulation |
| WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
| WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
| CN105078963B (en) * | 2015-09-29 | 2018-06-22 | 中山大学 | Alpha-tocopherol is preparing the application in treating snail fever drug |
| JP2020503269A (en) | 2016-11-28 | 2020-01-30 | リポカイン インコーポレーテッド | Oral testosterone undecanoate therapy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SA95160463B1 (en) * | 1994-12-22 | 2005-10-04 | استرا أكتيبولاج | powders for inhalation |
-
1998
- 1998-06-08 JP JP50548099A patent/JP2002510311A/en active Pending
- 1998-06-08 WO PCT/SE1998/001090 patent/WO1999000111A1/en not_active Application Discontinuation
- 1998-06-08 AU AU79456/98A patent/AU729100B2/en not_active Ceased
- 1998-06-08 KR KR1019997012234A patent/KR20010014163A/en not_active Application Discontinuation
- 1998-06-08 SK SK1848-99A patent/SK184899A3/en unknown
- 1998-06-08 IL IL13347898A patent/IL133478A0/en unknown
- 1998-06-08 EP EP98929963A patent/EP1001749A1/en not_active Withdrawn
- 1998-06-08 NZ NZ501672A patent/NZ501672A/en unknown
- 1998-06-08 PL PL98337723A patent/PL337723A1/en unknown
- 1998-06-08 TR TR1999/03271T patent/TR199903271T2/en unknown
- 1998-06-08 CN CN98806377A patent/CN1260713A/en active Pending
- 1998-06-08 BR BR9810280-0A patent/BR9810280A/en not_active IP Right Cessation
- 1998-06-08 ID IDW991656A patent/ID23192A/en unknown
- 1998-06-08 CA CA002295028A patent/CA2295028A1/en not_active Abandoned
- 1998-06-08 HU HU0003207A patent/HUP0003207A3/en unknown
- 1998-06-08 EE EEP199900601A patent/EE9900601A/en unknown
-
1999
- 1999-12-15 IS IS5304A patent/IS5304A/en unknown
- 1999-12-23 NO NO996439A patent/NO996439L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0003207A2 (en) | 2001-02-28 |
| AU7945698A (en) | 1999-01-19 |
| PL337723A1 (en) | 2000-08-28 |
| EE9900601A (en) | 2000-08-15 |
| TR199903271T2 (en) | 2000-08-21 |
| ID23192A (en) | 2000-03-23 |
| JP2002510311A (en) | 2002-04-02 |
| CN1260713A (en) | 2000-07-19 |
| SK184899A3 (en) | 2000-05-16 |
| WO1999000111A1 (en) | 1999-01-07 |
| BR9810280A (en) | 2000-09-12 |
| EP1001749A1 (en) | 2000-05-24 |
| CA2295028A1 (en) | 1999-01-07 |
| NO996439L (en) | 2000-02-28 |
| NZ501672A (en) | 2001-06-29 |
| IS5304A (en) | 1999-12-15 |
| NO996439D0 (en) | 1999-12-23 |
| IL133478A0 (en) | 2001-04-30 |
| AU729100B2 (en) | 2001-01-25 |
| KR20010014163A (en) | 2001-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS1978B (en) | Medicinal preparations containing proliposome powder for inhalation | |
| EP0768094A3 (en) | Powder inhalation medication | |
| HUP0100950A3 (en) | Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| HK1021323A1 (en) | Preparation of powder agglomerates. | |
| HUP0002538A3 (en) | Inhaler for powdered medicaments | |
| HUP9901159A3 (en) | Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds | |
| NZ304901A (en) | Taxoid derivatives, preparation thereof and pharmaceutical compositions containing same | |
| HUP0104195A3 (en) | Vitamin d analogues, preparation thereof, pharmaceutical and cosmetic compositions containing them | |
| AU5889398A (en) | Powder inhaler | |
| IL115039A (en) | Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them | |
| HUT76900A (en) | Dry powder inhalator medicament carrier | |
| HUP0001652A3 (en) | Oxadiazole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them | |
| HUP9901037A3 (en) | Piperazine derivatives,preparation and use thereof, pharmaceutical compositions containing these compounds | |
| HUP9904046A3 (en) | Novel taxoids, preparation thereof and pharmaceutical compositions containing the same | |
| IL106600A (en) | Peptides, pharmaceutical compositions containing the same and processes for the preparation thereof | |
| IL112193A0 (en) | Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0004926A3 (en) | 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring, pharmaceutical compositions containing them and their use | |
| HUP0000851A3 (en) | Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them | |
| HUP0002517A3 (en) | Derivatives of acyl-piperazinil-pyrimidins, preparation thereof, pharmaceutical compositions containing them and their use as medicaments | |
| HUP0003207A3 (en) | Proliposome powders for inhalation stabilised by tocopherol, pharmaceutical compositions containing the same and the use of them | |
| HUP0004226A3 (en) | Novel vitamin d analogues, pharmaceutical compositions containing thereof and process for preparing the same | |
| IL137494A0 (en) | Polypeptide compounds, process for the preparation thereof and pharmaceutical compositions containing the same | |
| IL112443A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical compositions containing them | |
| EP1004296A4 (en) | Powder containing fat-soluble drug | |
| HUP0004561A3 (en) | Dihydrobenzofurans, pharmaceutical compositions containing them and use thereof |